about
P1889
Lipid Geometry and Bilayer Curvature Modulate LC3/GABARAP-Mediated Model Autophagosomal ElongationHuman Atg8-cardiolipin interactions in mitophagy: Specific properties of LC3B, GABARAPL2 and GABARAPPhase diagrams of lipid mixtures relevant to the study of membrane rafts.Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environmentsSpectroscopic techniques in the study of membrane solubilization, reconstitution and permeabilization by detergents.Sphingomyelinases: enzymology and membrane activity.Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayersBiophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cellsSphingosine induces the aggregation of imine-containing peroxidized vesicles.Sec14-nodulin proteins and the patterning of phosphoinositide landmarks for developmental control of membrane morphogenesisIn situ synthesis of fluorescent membrane lipids (ceramides) using click chemistry.Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids.Membrane organization and ionization behavior of the minor but crucial lipid ceramide-1-phosphate.Effects of ceramide and other simple sphingolipids on membrane lateral structure.Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.Phospholipases C and sphingomyelinases: Lipids as substrates and modulators of enzyme activity.Biophysical properties of sphingosine, ceramides and other simple sphingolipids.Cholesterol interactions with ceramide and sphingomyelin.Solid lipid nanoparticles for delivery of Calendula officinalis extract.End-product diacylglycerol enhances the activity of PI-PLC through changes in membrane domain structureHistones and DNA compete for binding polyphosphoinositides in bilayersCholesterol-Ceramide Interactions in Phospholipid and Sphingolipid Bilayers As Observed by Positron Annihilation Lifetime Spectroscopy and Molecular Dynamics Simulations.Triton X-100 partitioning into sphingomyelin bilayers at subsolubilizing detergent concentrations: effect of lipid phase and a comparison with dipalmitoylphosphatidylcholine.Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes.Lipidic nanovesicles stabilize suspensions of metal oxide nanoparticles.Palmitoylcarnitine, a surface-active metabolite.Membrane permeabilization induced by sphingosine: effect of negatively charged lipids.Combination of the anti-tumour cell ether lipid edelfosine with sterols abolishes haemolytic side effects of the drug.Atomic force microscopy characterization of palmitoylceramide and cholesterol effects on phospholipid bilayers: a topographic and nanomechanical study.The biosynthetic incorporation of diacetylenic fatty acids into the biomembranes of Acholeplasma laidlawii A cells and polymerisation of the biomembranes by irradiation with ultraviolet light.Thermally-induced aggregation and fusion of protein-free lipid vesicles.End-products diacylglycerol and ceramide modulate membrane fusion induced by a phospholipase C/sphingomyelinase from Pseudomonas aeruginosaCholesterol displaces palmitoylceramide from its tight packing with palmitoylsphingomyelin in the absence of a liquid-disordered phase.Histones cause aggregation and fusion of lipid vesicles containing phosphatidylinositol-4-phosphate.Sphingosine increases the permeability of model and cell membranesLamellar gel (lβ) phases of ternary lipid composition containing ceramide and cholesterol.A cholesterol recognition motif in human phospholipid scramblase 1.High-melting lipid mixtures and the origin of detergent-resistant membranes studied with temperature-solubilization diagramsAccumulated bending energy elicits neutral sphingomyelinase activity in human red blood cells.Lipid bilayers in the gel phase become saturated by triton X-100 at lower surfactant concentrations than those in the fluid phase.
P50
Q28384856-E013CFD3-C5A4-4793-9381-3237188D6F83Q28396855-94B2BCA9-A5EA-4AC7-B27C-3F7B71289A7BQ30485547-3B12024B-B9D9-41B8-95ED-692D090C0AC2Q33498660-EF77CD9C-D29F-424E-A9FE-9CF2BE1820A6Q34088665-190E27DD-BEDC-4804-9363-C1A2C336FAF7Q34156320-22DE78A4-8AD8-4419-A924-87ABFB2AA16EQ34353229-A501F253-C846-4584-A208-286799680396Q34727686-479A1D2F-AD68-42F0-9A41-A5E0FBF3A1FFQ35164012-0AF3C97E-5404-4171-B097-1FAAC2474E49Q35621839-6D231DD7-D96C-46FA-B88F-C824F184323DQ36032662-0425F49B-3159-4926-B9A5-991192EBEE67Q36637060-4FE96217-E0A5-40B9-8E97-D73EC56BE6ADQ36785170-0D503CA0-7931-4B07-B537-8235F36C099EQ37291700-60AC7632-B7BC-4415-B537-D6C99A45F193Q37405849-D8AB059D-044A-4DED-A95F-8F0BD6E9B971Q38002733-23D3900E-FBB6-4503-9760-3E1498B6B93AQ38252307-896F8F0B-77B2-4048-A57F-A6ECC11FDC8BQ38821945-F44B6AF3-39D2-40FC-99ED-3B0590196274Q38847487-25C1B7B6-77CE-4734-865A-9C4C0158E9D6Q39427249-ECB5E657-09AA-47D5-B8C8-C17A71A9B77EQ39759894-43443431-9AC4-4EEB-A238-F1D6EE7BE2CFQ39783727-805E4E6B-02EB-4394-96E5-78B6D524BC38Q39939427-88858666-12FD-4962-8B45-45AB1E4F3D25Q40311939-671F0F6C-24A7-44C9-BF05-A0249730FA08Q40613289-5AB38BF4-02C2-413D-9DF1-467EE548CC7EQ41032626-AC571250-E4AF-48B2-B1EF-E31F418BC9AEQ41142901-72BE4AC0-9E94-4947-A236-8DA88D7A9968Q41372981-0914C2FD-6332-4C8C-895F-D27D989E9C7FQ41398497-8A06685F-3947-4A9E-A872-CDD8EB756406Q41449239-CD9C71B7-6F23-4E7A-8A08-F513CB50242CQ41603956-20A24DFC-69B8-40E6-9325-E79C4747C5B4Q41620115-72D18475-7FF1-4C74-A86A-A706ABA205F4Q41819742-4EEBEC5F-8DA8-4B65-BF4B-D73BB69D6235Q41842010-D6567628-5FE8-453A-9717-37F18E16FDD9Q41934099-087D0C2A-6D1C-47C9-A378-70FB1837C1ADQ42004190-D7AEFD41-CAE0-46A4-90B0-E78A91A51EF0Q42094385-E748EE71-7396-4DF4-B841-9E1BAFB5F334Q42117580-74051313-4392-410D-B517-DBCA501650CFQ42143355-CAEB2D33-D843-45CF-98AB-25EDFA421FBAQ42184753-EDC0B7AD-518E-4BF8-9C70-F32E8FD798C7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alicia Alonso
@ast
Alicia Alonso
@en
Alicia Alonso
@es
Alicia Alonso
@nl
type
label
Alicia Alonso
@ast
Alicia Alonso
@en
Alicia Alonso
@es
Alicia Alonso
@nl
prefLabel
Alicia Alonso
@ast
Alicia Alonso
@en
Alicia Alonso
@es
Alicia Alonso
@nl
P1053
E-5310-2012
P106
P1889
P21
P31
P3829
P496
0000-0002-2730-7470